Clinical Trial Update: Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication [Phase 4]

View source ↗

Summary

Phase 4 study assessing the efficacy and safety of vonoprazan-based berberine triple therapy for first-line eradication of Helicobacter pylori has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastritis
• Helicobacter Pylori Infection

Drugs mentioned

• Berberine (berberine)
• Vonoprazan (vonoprazan)

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Helicobacter Pylori Infection, Chronic Gastritis | Phase 4 | Status: COMPLETED